19 May 2013
Keywords: emea, creates, precedent, biosimilars, approvals, biogeneric, versions
Article | 02 July 2007
Sandoz, the generics unit of Swiss drug major Novartis, has received a positive opinion from European Union regulators supporting the
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
2 July 2007
17 May 2013
© 2013 thepharmaletter.com